{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:08Z","timestamp":1787698268010,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J CARS"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s11548-014-1115-8","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T06:27:32Z","timestamp":1410416852000},"page":"993-1002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer"],"prefix":"10.1007","volume":"10","author":[{"given":"Meltem","family":"Caglar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Yener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"issue":"3","key":"1115_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/bjs.1800830305","volume":"83","author":"PM Sagar","year":"1996","unstructured":"Sagar PM, Pemberton JH (1996) Surgical management of locally recurrent rectal cancer. Br J Surg 83(3):293\u2013304","journal-title":"Br J Surg"},{"issue":"1","key":"1115_CR2","first-page":"27","volume":"174","author":"S Galandiuk","year":"1992","unstructured":"Galandiuk S, Wieland HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, Wolff BG (1992) Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174(1):27\u201332","journal-title":"Surg Gynecol Obstet"},{"issue":"8","key":"1115_CR3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s00259-011-1785-1","volume":"38","author":"M Maas","year":"2011","unstructured":"Maas M, Rutten IJ, Nelemans PJ, Lambregts DM, Cappendijk VC, Beets GL, Beets-Tan RG (2011) What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 38(8):1560\u20131571","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1115_CR4","doi-asserted-by":"crossref","unstructured":"Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C (1993) An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270(8):943\u2013947","DOI":"10.1001\/jama.1993.03510080047030"},{"issue":"2","key":"1115_CR5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1148\/radiology.182.2.1732979","volume":"82","author":"K Ito","year":"1992","unstructured":"Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, Sakuma S (1992) Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 82(2):549\u201352","journal-title":"Radiology"},{"key":"1115_CR6","doi-asserted-by":"crossref","unstructured":"O\u2019Connor OJ, McDermott S, Slattery J, Sahani D, Blake MA (2011) The Use of PET-CT in the assessment of patients with colorectal carcinoma. Int J Surg Oncol 2011: Article ID 846512, 14\u00a0pp. doi: 10.1155\/2011\/846512","DOI":"10.1155\/2011\/846512"},{"issue":"5","key":"1115_CR7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0748-7983(95)97046-0","volume":"21","author":"C Schiepers","year":"1995","unstructured":"Schiepers C, Penninckx F, De Vadder N, Merckx E, Mortelmans L, Bormans G, Marchal G, Filez L, Aerts R (1995) Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 21(5):517\u2013521","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"1115_CR8","first-page":"492","volume":"43","author":"V Kalff","year":"2002","unstructured":"Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF (2002) The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 43(4):492\u2013499","journal-title":"J Nucl Med"},{"issue":"12","key":"1115_CR9","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s002590100646","volume":"28","author":"T Arulampalam","year":"2001","unstructured":"Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P (2001) The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl 28(12):1758\u20131765","journal-title":"Eur J Nucl"},{"issue":"7","key":"1115_CR10","first-page":"1177","volume":"41","author":"RH Huebner","year":"2000","unstructured":"Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41(7):1177\u20131189","journal-title":"J Nucl Med"},{"issue":"5 Suppl","key":"1115_CR11","first-page":"1S","volume":"42","author":"SS Gambhir","year":"2001","unstructured":"Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42(5 Suppl):1S\u201393S","journal-title":"J Nucl Med"},{"issue":"10","key":"1115_CR12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7150\/thno.5629","volume":"3","author":"B Bai","year":"2013","unstructured":"Bai B, Bading J, Conti PS (2013) Tumor quantification in clinical positron emission tomography. Theranostics 3(10):787\u2013801","journal-title":"Theranostics"},{"issue":"5 suppl 1","key":"1115_CR13","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(5 suppl 1):122S\u2013150S","journal-title":"J Nucl Med"},{"issue":"3","key":"1115_CR14","first-page":"272","volume":"3","author":"SA Esfahani","year":"2013","unstructured":"Esfahani SA, Heidari P, Halpern EF, Hochberg EP, Palmer EL, Mahmood U (2013) Baseline total lesion glycolysis measured with (18) F-FDG PET\/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study. Am J Nucl Med Mol Imaging 3(3):272\u2013281","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"1115_CR15","doi-asserted-by":"crossref","unstructured":"Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, Casilla C, Fazzari M, Srivastava N, Yeung HW, Humm JL, Guillem J, Downey R, Karpeh M, Cohen AE, Ginsberg R (1999) Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and change in total lesion glycolysis. Clin Positron Imaging 2(3): 159\u2013171","DOI":"10.1016\/S1095-0397(99)00016-3"},{"issue":"9","key":"1115_CR16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/MNM.0b013e32835673ec","volume":"33","author":"K Manohar","year":"2012","unstructured":"Manohar K, Mittal BR, Bhattacharya A, Malhotra P, Varma S (2012) Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with high-grade non-Hodgkin\u2019s lymphoma. Nucl Med Commun 33(9):974\u2013981","journal-title":"Nucl Med Commun"},{"issue":"1","key":"1115_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00259-011-1934-6","volume":"39","author":"S Liao","year":"2012","unstructured":"Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, Shih MC, Shimada N, Chen S, Salgia R, Appelbaum DE, Suzuki K, Chen CT, Pu Y (2012) Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 39(1):27\u201338","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1115_CR18","first-page":"493","volume":"39","author":"HJ Jo","year":"2014","unstructured":"Jo HJ, Kim SJ, Lee HY, Kim IJ (2014) Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET\/CT in patients with surgically resected rectal cancer. Clin Nucl Med 39(6):493\u2013497","journal-title":"Clin Nucl Med"},{"key":"1115_CR19","doi-asserted-by":"crossref","unstructured":"Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW Jr (2007) Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys 69(2):328\u2013333","DOI":"10.1016\/j.ijrobp.2007.04.036"},{"issue":"1","key":"1115_CR20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0972-3919.84598","volume":"26","author":"A Gupta","year":"2011","unstructured":"Gupta A, Sharma P, Patel CD, Maharjan S, Pandey A, Kumar R, Malhotra A (2011) Size-dependent thresholding as an optimal method for tumor volume delineation on positron emission tomography-computed tomography: a phantom study. Indian J Nucl Med 26(1):22\u201326","journal-title":"Indian J Nucl Med"},{"issue":"11","key":"1115_CR21","first-page":"1808","volume":"47","author":"KJ Biehl","year":"2006","unstructured":"Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD (2006) 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 47(11):1808\u20131812","journal-title":"J Nucl Med"},{"issue":"2","key":"1115_CR22","first-page":"88","volume":"46","author":"A Ugrinska","year":"2002","unstructured":"Ugrinska A, Bombardieri E, Stokkel MP, Crippa F, Pauwels EK (2002) Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer. Q J Nucl Med 46(2):88\u2013104","journal-title":"Q J Nucl Med"},{"issue":"3","key":"1115_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MEG.0b013e328343eaa0","volume":"3","author":"C Deleau","year":"2011","unstructured":"Deleau C, Buecher B, Rousseau C, Kraeber-Bod\u00e9r\u00e9 F, Flamant M (2011) Clinical impact of fluorodeoxyglucose-positron emission tomography scan\/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence. Eur J Gastroenterol Hepatol 3(3):275\u2013281","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"1115_CR24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MNM.0b013e3283477dd7","volume":"32","author":"BR Mittal","year":"2011","unstructured":"Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh B, Kapoor R, Gupta R (2011) 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level. Nucl Med Commun 32(9):789\u2013793","journal-title":"Nucl Med Commun"},{"issue":"3","key":"1115_CR25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2214\/AJR.09.3205","volume":"194","author":"U Metser","year":"2010","unstructured":"Metser U, You J, McSweeney S, Freeman M, Hendler A (2010) Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET\/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. Am J Roentgenol 194(3):766\u2013771","journal-title":"Am J Roentgenol"},{"issue":"6","key":"1115_CR26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02238010","volume":"43","author":"MH Whiteford","year":"2000","unstructured":"Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE (2000) Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43(6):759\u2013767","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"1115_CR27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2214\/ajr.174.4.1741005","volume":"174","author":"KL Berger","year":"2000","unstructured":"Berger KL, Nicholson SA, Dehdashti F, Siegel BA (2000) FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. Am J Roentgenol 174(4):1005\u20131008","journal-title":"Am J Roentgenol"},{"issue":"1","key":"1115_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2214\/ajr.177.1.1770123","volume":"177","author":"A Rieber","year":"2001","unstructured":"Rieber A, N\u00fcssle K, St\u00f6hr I, Grab D, Fenchel S, Kreienberg R, Reske SN, Brambs HJ (2001) Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol 177(1):123\u2013129","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"1115_CR29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF02303744","volume":"4","author":"OA Ogunbiyi","year":"1997","unstructured":"Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, Fleshman JW, Read TE, Philpott GW, Kodner IJ (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4(8):613\u2013620","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1115_CR30","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1102\/1470-7330.2006.9014","volume":"31","author":"LF Geus-Oei de","year":"2006","unstructured":"de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ (2006) FDG-PET in colorectal cancer. Cancer Imaging 31(6):S71\u2013S81","journal-title":"Cancer Imaging"},{"issue":"3","key":"1115_CR31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiol.2323031065","volume":"232","author":"E Even-Sapir","year":"2004","unstructured":"Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, Figer A, Metser U (2004) Detection of recurrence in patients with rectal cancer: PET\/CT after abdominoperineal or anterior resection. Radiology 232(3):815\u2013822","journal-title":"Radiology"},{"issue":"4","key":"1115_CR32","first-page":"315","volume":"94","author":"T Kau","year":"2009","unstructured":"Kau T, Reinprecht P, Eicher W, Lind P, Starlinger M, Hausegger KA (2009) FDG PET\/CT in the detection of recurrent rectal cancer. Int Surg 94(4):315\u2013324","journal-title":"Int Surg"},{"issue":"1","key":"1115_CR33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1072-7515(03)00337-5","volume":"197","author":"HG Moore","year":"2003","unstructured":"Moore HG, Akhurst T, Larson SM, Minsky BD, Mazumdar M, Guillem JG (2003) A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197(1):22\u201328","journal-title":"J Am Coll Surg"},{"key":"1115_CR34","unstructured":"Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N (1994) Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 35(1):104\u2013112"},{"key":"1115_CR35","doi-asserted-by":"crossref","unstructured":"Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, Pruim J, Price P (1999) Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35(13):1773\u20131782","DOI":"10.1016\/S0959-8049(99)00229-4"},{"issue":"10","key":"1115_CR36","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s10350-005-0097-6","volume":"8","author":"FY Liu","year":"2005","unstructured":"Liu FY, Chen JS, Changchien CR, Yeh CY, Liu SH, Ho KC, Yen TC (2005) Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels. Dis Colon Rectum 8(10):1900\u20131912","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"1115_CR37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/j.semnuclmed.2005.12.002","volume":"36","author":"FP Esteves","year":"2006","unstructured":"Esteves FP, Schuster DM, Halkar RK (2006) Gastrointestinal tract malignancies and positron emission tomography: an overview. Semin Nucl Med 36(2):169\u2013181","journal-title":"Semin Nucl Med"},{"issue":"9","key":"1115_CR38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/BF02052591","volume":"37","author":"JL McCall","year":"1994","unstructured":"McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, Toouli J (1994) The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 37(9):875\u2013881","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"1115_CR39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3816\/CBC.2008.n.042","volume":"8","author":"A Saad","year":"2008","unstructured":"Saad A, Kanate A, Sehbai A, Marano G, Hobbs G, Abraham J (2008) Correlation among [18F]fluorodeoxyglucose positron emission tomography\/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer. Clin Breast Cancer 8(4):357\u2013361","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"1115_CR40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00259-010-1626-7","volume":"38","author":"L Evangelista","year":"2011","unstructured":"Evangelista L, Baretta Z, Vinante L, Cervino AR, Gregianin M, Ghiotto C, Saladini G, Sotti G (2011) Tumour markers and FDG PET\/CT for prediction of disease relapse in patients with breast cancer. Eur J Nucl Med Mol Imaging 38(2):293\u2013301","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1115_CR41","unstructured":"Nagamachi S, Wakamatsu H, Kiyohara S, Fujita s, Nishii R, Arita h, Futami S, Tamura S (2009) Which FDG Pet\/CT quantitative indices (SUVmax, metabolic volume total lesion glycolysis) correlate well with serum tumor markers in NSCLC, colon cancer and pancreatic cancer? J Nucl Med 50(suppl 2):1722"}],"container-title":["International Journal of Computer Assisted Radiology and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11548-014-1115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11548-014-1115-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11548-014-1115-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T11:36:12Z","timestamp":1717328172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11548-014-1115-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,12]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1007\/s11548-014-1115-8","relation":{},"ISSN":["1861-6410","1861-6429"],"issn-type":[{"value":"1861-6410","type":"print"},{"value":"1861-6429","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,12]]}}}